|
|
Volumn 33, Issue 7-8, 2001, Pages 3201-3202
|
|
Use of basiliximab in conjunction with either Neora/MMF/steroids or Prograf/MMF/steroids in simultaneous pancreas-kidney transplantation
a,b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CALCINEURIN INHIBITOR;
CYCLOSPORIN A;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
TACROLIMUS;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
GRAFT INFECTION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INFECTION RATE;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
MALE;
PANCREAS TRANSPLANTATION;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
RECIPIENT;
SURVIVAL RATE;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
ANTIBODIES, MONOCLONAL;
CAUSE OF DEATH;
CYCLOSPORINE;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
MYCOPHENOLIC ACID;
PANCREAS TRANSPLANTATION;
RECOMBINANT FUSION PROTEINS;
SAFETY;
STEROIDS;
TACROLIMUS;
|
|
EID: 0035679765
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(01)02362-4 Document Type: Article |
|
Times cited : (8)
|
|
References (9)
|
